Mather Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Buy
46,149
+43,189
+1,459% +$2.84M 0.03% 215
2026
Q1
$211K Sell
2,960
-224
-7% -$17.7K ﹤0.01% 723
2025
Q4
$261K Buy
3,184
+1,301
+69% +$101K ﹤0.01% 555
2025
Q3
$141K Buy
+1,883
New +$140K ﹤0.01% 696
2025
Q2
Sell
-2,777
Closed -$224K 1037
2025
Q1
$224K Buy
2,777
+800
+40% +$68.8K ﹤0.01% 559
2024
Q4
$155K Buy
1,977
+247
+14% +$21K ﹤0.01% 643
2024
Q3
$162K Sell
1,730
-93
-5% -$7.81K ﹤0.01% 634
2024
Q2
$166K Buy
1,823
+660
+57% +$53.8K ﹤0.01% 662
2024
Q1
$89.9K Buy
+1,163
New +$96.8K ﹤0.01% 726

Other funds holding GEHC

Mather Group's GEHC Position: Q2 2026 in Review

Mather Group increased its GE HealthCare (GEHC) stake by 1,459% in Q2 2026, buying an estimated $2.84M and bringing the position to 46,149 shares worth $2.95M. The position accounts for 0.03% of the portfolio, ranked #215.

Mather Group first reported a position in GEHC in Q1 2024 and has held it in 9 quarters since. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Mather Group held 46,149 shares of GE HealthCare worth $2.95M as of Q2 2026.
  • Mather Group bought 43,189 GE HealthCare shares in Q2 2026, an estimated $2.84M.
  • GE HealthCare made up 0.03% of Mather Group's portfolio in Q2 2026, its #215 holding.
  • Mather Group first reported a position in GE HealthCare in Q1 2024 and has held it in 9 quarters since.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.